0 Multiple Myeloma Drug: AbbVie’s Proven Candidate Seeks Approval October 28, 2026 Dr. Roza Riyan Multiple myeloma drug candidates are crucial in advancing treatment options. AbbVie seeks FDA approval for its latest candidate.
0 Is the Bile Duct Cancer Drug Approval a Smart Move? September 28, 2026 Dr. Roza Riyan Bile duct cancer drug approval brings hope for patients. What does it mean?